Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Al Pinna is active.

Publication


Featured researches published by Al Pinna.


Journal of The European Academy of Dermatology and Venereology | 2012

Cutaneous adverse drug reactions to allopurinol: 10 year observational survey of the dermatology department – Cagliari University (Italy)

Laura Atzori; Al Pinna; L Mantovani; Caterina Ferreli; Monica Pau; M. Mulargia; N. Aste

Background  Allopurinol is extensively prescribed for conditions associated with urate excess, despite being responsible for severe cutaneous adverse drug reactions (ADR).


Mycoses | 2009

Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor

N. Aste; Monica Pau; Al Pinna; M. D. Colombo; P. Biggio

Summary. The antifungal efficacy and tolerability of 1% terbinafine cream vs. 1% bifonazole cream were assessed in a single blind randomized trial in patients with pityriasis versicolor. Terbinafine, a drug of the allylamines group, a new class of antimycotic agents, blocks sterol biosynthesis in the pathogen through inhibition of squalene epoxidase and consequent squalene accumulation, a primarily fungicidal process. Forty pityriasis versicolor patients, (18 M, 22 F; mean age 32.4 years; min. 16, max. 65), used 1% terbinafine cream or 1% bifonazole cream for a maximum of 4 weeks. All patients were followed‐up weekly both clinically and my‐cologically. Clinical cures, defined as negativization of each clinical parameter, were recorded for 20 terbinafine patients (100%) and 19 bifonazole patients (95%), with routine microscopy and Woods light tests both negative. By the 2nd week of treatment, 2 terbinafine patients were mycologically cured (10%). By the 3rd week, 14 terbinafine patients (70%) and 5 bifonazole patients (25%) were mycologically cured. The present controlled clinical trial consequently demonstrates that terbinafine is rapidly effective and well tolerated for treatment of pityriasis versicolor.


Journal of The European Academy of Dermatology and Venereology | 2006

Amniotic membrane transplantation in the surgical management of symblepharon following toxic epidermal necrolysis

Laura Atzori; Enrico Peiretti; Caterina Ferreli; Al Pinna; Maurizio Fossarello; N. Aste

Toxic epidermal necrolysis (TEN) is a rare, potentially life-threatening acute condition, whose pathophysiology is not completely understood, but there is a certain agreement that it consists of a cell-mediated cytotoxic reaction against keratinocytes, altered by drugs or their metabolites. 1–3 Early recognition and withdrawal of the suspected drug are the main recommended procedures. 3 Therapeutic goals in the acute phase are directed toward promotion of wound healing, prevention of sepsis and management of multisystem failure. 4 In those patients who survive, ocular complications represent the most significant long-term sequelae and occurs in about 50% of cases. 5


Journal of The European Academy of Dermatology and Venereology | 2015

Granulomatous reactions after injections of multiple aesthetic micro-implants in temporal combinations: a complication of filler addiction

Franco Rongioletti; Laura Atzori; Caterina Ferreli; Monica Pau; Al Pinna; S. R. Mercuri; N. Aste; Sylvie Fraitag

Granulomatous reaction is a well‐known complication following soft filler procedures. However, the diagnosis of filler‐induced granulomas may be challenging because of the occasional reluctance of patients to report the previously performed aesthetic procedure.


Journal of The European Academy of Dermatology and Venereology | 2017

Methimazole-induced chronic cutaneous lupus erythematosus.

M. Venturi; Caterina Ferreli; Al Pinna; Luca Pilloni; Laura Atzori; Franco Rongioletti

T. Dainichi, T. Tanaka, K. Izawa, R. Nishikomori, K. Kabashima* Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan, Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan, Singapore Immunology Network (SIgN) and Institute of Medical Biology, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore *Correspondence: S. Nakamizo and K. Kabashima. E-mails: s.nakami@ kuhp.kyoto-u.ac.jp; [email protected]


Journal of The European Academy of Dermatology and Venereology | 1999

Eosinophilic cellulitis (Wells' syndrome): a new case description

Caterina Ferreli; Al Pinna; Laura Atzori; N. Aste


Journal of The European Academy of Dermatology and Venereology | 2003

IgA pemphigus of the subcorneal pustular dermatosis type associated with monoclonal IgA gammopathy

N. Aste; G Fumo; Al Pinna; P. Biggio


Journal of The European Academy of Dermatology and Venereology | 2004

'Pityriasis rosea-like' adverse reaction to lisinopril

Laura Atzori; Caterina Ferreli; Al Pinna; N. Aste


Journal of The European Academy of Dermatology and Venereology | 2003

Extensive and recalcitrant verrucae vulgares of the great toe treated with imiquimod 5% cream

Laura Atzori; Al Pinna; Caterina Ferreli


Redia-Giornale Di Zoologia | 2015

Diffuse dermal angiomatosis: a clinical mimicker of vasculitis associated with calciphylaxis and monoclonal gammopathy.

Caterina Ferreli; Laura Atzori; Al Pinna; Monica Pau; N. Aste; Carlos Ricotti; Franco Rongioletti

Collaboration


Dive into the Al Pinna's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

N. Aste

University of Cagliari

View shared research outputs
Top Co-Authors

Avatar

Monica Pau

University of Cagliari

View shared research outputs
Top Co-Authors

Avatar

P. Biggio

University of Cagliari

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

G Fumo

University of Cagliari

View shared research outputs
Top Co-Authors

Avatar

L Mantovani

University of Cagliari

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge